Why Are Jaguar Health Shares Surging Today?

  • Continuing Friday's rally, Jaguar Health Inc (NASDAQ: JAGX) stock has surged on Monday as the investors react to the news of its third royalty financing agreement announced on Friday.
  • The company entered a binding term sheet for $5 million a royalty interest in future potential crofelemer (Mytesi) sales for the proposed COVID-related indication in long-hauler patients.
  • JAGX is currently pursuing conditional marketing authorization in the European Union.
  • This financing follows two royalty transactions, including $5 million announced in October and $6 million finalized in December.
  • Price Action: On the last check, JAGX surged 48.8% at $2.39 in market trading hours.
Loading...
Loading...
JAGX Logo
JAGXJaguar Health Inc
$3.73-1.78%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
1.23
Growth
Not Available
Quality
Not Available
Value
37.67
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Comments
Loading...